Search Results 261-270 of 23900 for prostate cancer
177Lu-PSMA-617 vs. Androgen Receptor-directed Therapy in the Treatment of Progressive Metastatic Castrate Resistant Prostate Cancer. Print details. Share ...
Navigating therapeutic sequencing in the metastatic castration-resistant prostate cancer patient journey. Prostate Cancer Prostatic Dis. 2024 Oct 17 [Epub ...
Examples of tumor markers include prostate-specific antigen (PSA) for prostate cancer and cancer antigen 125 (CA 125) for ovarian cancer. Other examples ...
... prostate cancer. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kill more tumor cells ...
"Men with stress incontinence after treatment for prostate cancer often have trialed conservative therapies, including pelvic floor muscle exercises. These ...
... tumor mutation burden-high metastatic castration-resistant prostate cancer: outcome analysis. Prostate Cancer Prostatic Dis. 2025 Mar; 28 (1):138-144 Epub ...
Many patients with prostate cancer, bladder cancer and kidney cancer are curable with surgery. One thing that makes Mayo Clinic unique is we have specially ...
In this Medical Edge Radio episode, Mayo Clinic Dr. Daniel Elliott discusses incontinence after surgery for prostate cancer. To listen, click the link below.
The prostate gland is present only in males; therefore, females do not get prostate cancer. This medicine blocks the effect of the male hormone testosterone in ...
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy · Overview · Participation ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.